# FDA Inspection 1231238 - Imprimis NJOF, LLC - April 03, 2024

Source: https://www.keypedia.com/records/fda_inspections/imprimis-njof-llc/6ccdf0f4-5b8b-4f85-ae41-5531cf4b6475
Source feed: FDA_Inspections

> FDA Inspection 1231238 for Imprimis NJOF, LLC on April 03, 2024. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1231238
- Company Name: Imprimis NJOF, LLC
- Inspection Date: 2024-04-03
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1135834 - 2021-01-29](https://www.keypedia.com/records/fda_inspections/imprimis-njof-llc/8a50e769-ce1f-4047-9453-802e1f061ba1)
- [FDA Inspection 1024871 - 2017-07-10](https://www.keypedia.com/records/fda_inspections/imprimis-njof-llc/97faa7aa-4a74-4671-bec4-d61f8fc746d4)

Company: https://www.keypedia.com/companies/imprimis-njof-llc/7720fb39-8798-4cfd-9e08-9e0f77adaa2c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
